The nearly 1 million people around the world who have lost their lives to COVID-19 have left us a gift: Through desperate efforts to save their lives, scientists now better understand how to treat and prevent the disease — and millions of others may survive.
Ming Wang, 71, and his wife were on a cruise from Australia, taking a break after decades of running the family's Chinese restaurant in Papillion, Nebraska, when he was infected. In the 74 days he was hospitalized before his death in June, doctors frantically tried various experimental approaches, including enrolling him in a study of an antiviral drug that ultimately showed promise.
"It was just touch and go. Everything they wanted to try we said yes, do it," said Wang's daughter, Anne Peterson. "We would give anything to have him back, but if what we and he went through would help future patients, that's what we want."
Patients are already benefiting. Though more deaths are expected this fall because of the recent surge in coronavirus infections in the U.S. and elsewhere, there also are signs that death rates are declining and that people who get the virus now are faring better than did those in the early months of the pandemic.
"Some of the reason we're doing better is because of the advances," Dr. Francis Collins, director of the U.S. National Institutes of Health, told The Associated Press. Several drugs have proved useful and doctors know more about how to care for the sickest patients in hospitals, he said.
We're in the "stormy adolescence" phase of learning what treatments work — beyond infancy but not "all grown up either," Collins said.